Patents by Inventor Matthew Wintle

Matthew Wintle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Patent number: 8389472
    Abstract: The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases.
    Type: Grant
    Filed: August 21, 2006
    Date of Patent: March 5, 2013
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Alain D. Baron, Dennis Kim, David G. Maggs, Matthew Wintle
  • Uses of Glucoregulatory Proteins
    Publication number: 20090312246
    Abstract: The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases.
    Type: Application
    Filed: August 21, 2006
    Publication date: December 17, 2009
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Alain D. Baron, Dennis Kim, David G. Maggs, Matthew Wintle